Kathryn E. Hudson, MD, discusses the utility of liquid biopsy in lung cancer.
Kathryn E. Hudson, MD
Advertisement
Articles by Kathryn E. Hudson, MD
Kathryn E. Hudson, MD, discusses the rise of liquid biopsies as a tool for molecular testing in lung cancer.
Kathryn E. Hudson, MD, discusses performing repeat biopsies on patients with relapsed/refractory non–small cell lung cancer.
Kathryn E. Hudson, MD, discusses the utility of liquid biopsies in metastatic lung cancer.
Advertisement
Latest Updated Articles
Dr. Hudson on the Utility of Liquid Biopsy in Metastatic Lung CancerDecember 4th 2019
Dr. Hudson on Repeat Molecular Testing in Relapsed/Refractory NSCLCJanuary 17th 2020
Dr. Hudson on the Rise of Liquid Biopsies in Lung CancerJanuary 29th 2020
Dr. Hudson on the Utility of Liquid Biopsy in Lung CancerApril 15th 2020
Advertisement
Advertisement
Trending on OncLive
1
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
2
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
3
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
4
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
5